Latest News in the pharma Industry

Policy & Regulation

FDA Final Rule Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products

FDA Final Rule Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products

3 Aug 2015

Read more 
Catalent's OptiShell Technology is Delivery Platform for OPKO Health's New Chronic Kidney Disease Treatment

Catalent's OptiShell Technology is Delivery Platform for OPKO Health's New Chronic Kidney Disease Treatment

3 Aug 2015

Read more 
FDA Naming Guidance of Drug Products Containing Salt Drug Substances

FDA Naming Guidance of Drug Products Containing Salt Drug Substances

29 Jul 2015

Read more 
Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products

Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products

28 Jul 2015

Read more 
Regeneron and Sanofi Announce FDA Approval of Praluent Injection, the First PCSK9 Inhibitor in the US, for the Treatment of High LDL Cholesterol in Adult Patients

Regeneron and Sanofi Announce FDA Approval of Praluent Injection, the First PCSK9 Inhibitor in the US, for the Treatment of High LDL Cholesterol in Adult Patients

27 Jul 2015

Read more 
Merck Announces EMA Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection

Merck Announces EMA Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection

27 Jul 2015

Read more 
GSK’s Malaria Candidate Vaccine, Mosquirix Receives Positive Opinion from European Regulators for the Prevention of Malaria in Young Children in Sub-Saharan Africa

GSK’s Malaria Candidate Vaccine, Mosquirix Receives Positive Opinion from European Regulators for the Prevention of Malaria in Young Children in Sub-Saharan Africa

24 Jul 2015

Read more 
European Commission Approves Nivolumab BMS for Patients with Previously-Treated Advanced Squamous NSCLC

European Commission Approves Nivolumab BMS for Patients with Previously-Treated Advanced Squamous NSCLC

21 Jul 2015

Read more 
European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha (Evolocumab)

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha (Evolocumab)

21 Jul 2015

Read more 
Rx-360 Summary: Israel and Brazil API Standards Are Equivalent to EU

Rx-360 Summary: Israel and Brazil API Standards Are Equivalent to EU

20 Jul 2015

Read more 
European Commission Approves BMS’s Evotaz (Atazanavir and Cobicistat Fixed-Dose Combination) for the Treatment of HIV-1 Infection in Adults

European Commission Approves BMS’s Evotaz (Atazanavir and Cobicistat Fixed-Dose Combination) for the Treatment of HIV-1 Infection in Adults

17 Jul 2015

Read more 
World Courier Receives Wholesale Distribution Authorisation

World Courier Receives Wholesale Distribution Authorisation

16 Jul 2015

Read more